As members of Congress have joined with healthcare providers in demanding more clarity on how the federal government is allocating the limited supplies of remdesivir that Gilead Sciences Inc. is contributing to the Strategic National Stockpile for emergency use in the COVID-19 pandemic, the Federal Emergency Management Agency has announced a meeting to discuss ways to distribute medical resources more effectively in such pandemics.
Gilead is manufacturing the remdesivir, AmerisourceBergen is distributing it, and the federal government is allocating it. But where the buck...








